Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rook

Showing results (131-140 of 187) with videos related to

Pageof 19
Sort By:
Annals of the New York Academy of Sciences|October 31, 1996
The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphomaA H Rook, M Kubin, F E Fox, et al.
Journal of the American Academy of Dermatology|October 21, 2006
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoidesMadeleine Duvic, Matthew L Sherman, Gary S Wood, et al.
Clinical Lymphoma & Myeloma|November 21, 2007
Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12Maria Wysocka, Sarah Newton, Bernice M Benoit, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1995
IL-12 reverses cytokine and immune abnormalities in Sezary syndromeA H Rook, M Kubin, M Cassin, et al.
Journal of the American Academy of Dermatology|August 12, 2009
Extracorporeal photopheresis: past, present, and futureRobert Knobler, Mark L Barr, Daniel R Couriel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1985
Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanismA H Rook, J J Hooks, G V Quinnan, et al.
Journal of the American Academy of Dermatology|April 26, 2006
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosisRobert M Knobler, Lars E French, Youn Kim, et al.
Annals of Internal Medicine|October 1, 1984
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirusG V Quinnan, M Delery, A H Rook, et al.
Archives of Dermatology|March 1, 1992
Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trialA H Rook, B Freundlich, B V Jegasothy, et al.
Archives of Dermatology|August 8, 2002
Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institutionKaren Rebecca Suchin, Andrew J Cucchiara, Scott L Gottleib, et al.
Pageof 19

Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
Annals of the New York Academy of Sciences|October 31, 1996
The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphomaA H Rook, M Kubin, F E Fox, et al.
Journal of the American Academy of Dermatology|October 21, 2006
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoidesMadeleine Duvic, Matthew L Sherman, Gary S Wood, et al.
Clinical Lymphoma & Myeloma|November 21, 2007
Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12Maria Wysocka, Sarah Newton, Bernice M Benoit, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1995
IL-12 reverses cytokine and immune abnormalities in Sezary syndromeA H Rook, M Kubin, M Cassin, et al.
Journal of the American Academy of Dermatology|August 12, 2009
Extracorporeal photopheresis: past, present, and futureRobert Knobler, Mark L Barr, Daniel R Couriel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1985
Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanismA H Rook, J J Hooks, G V Quinnan, et al.
Journal of the American Academy of Dermatology|April 26, 2006
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosisRobert M Knobler, Lars E French, Youn Kim, et al.
Annals of Internal Medicine|October 1, 1984
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirusG V Quinnan, M Delery, A H Rook, et al.
Archives of Dermatology|March 1, 1992
Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trialA H Rook, B Freundlich, B V Jegasothy, et al.
Archives of Dermatology|August 8, 2002
Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institutionKaren Rebecca Suchin, Andrew J Cucchiara, Scott L Gottleib, et al.
Pageof 19